Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, TRADE SHOWS/SEMINARS/WEBINARS

Premier Health Announces Attendance at AlphaNorth Capital Investment Conference


VANCOUVER, British Columbia, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the "Company" or "Premier Health"), a company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it will be participating in the Alpha North Capital Investment Conference at the Grand Hyatt Baha Mar in the Bahamas from January 17 ? 19, 2020.

The conference introduces growth-stage companies across various sectors including technology, biotech and healthcare to top institutions and specialist brokers in North America through a full day series of one-on-one meetings between issuers and investors.

"We are excited to attend the AlphaNorth Conference for a second year in a row to communicate the progress on our story to Canadian, US and international investors providing them the opportunity to hear firsthand of our successes to date and growth plans moving forward," said Dr. Essam Hamza, CEO of Premier Health.

The company would also like to announce that it has also updated their corporate presentation for 2020. The presentation can be found at: https://www.mypremierhealth.com/wp-content/uploads/2020/01/PHGI-2020-01-09.pdf.

ON BEHALF OF THE BOARD OF DIRECTORS

"Dr. Essam Hamza, MD"
Chief Executive Officer                                                                                                             

About Premier Health

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are focused on innovative health care approaches that combine human skill-based expertise with emerging technologies. In conjunction with its subsidiary Cloud Practice, which offers SAAS based health technology solutions including a cloud based Electronic Medical Records (EMR) software, medical billing software and an online patient portal, the Company is developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). We currently have a combined ecosystem of 315 clinics, over 3000 licensed practitioners and almost 3 million registered patients. The Company recently acquired Livecare, a pioneer in telehealth and a key enabler for sustainable health in geographically disperse populations. The Premier Health team has deep clinical, operational and financial expertise and a passion for improving healthcare for all patients.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

FOR ADDITIONAL INFORMATION CONTACT:

Premier Health Group Inc.
www.mypremierhealth.com
Email: [email protected]

Renmark Financial Communications Inc.
Bettina Filippone: [email protected]
Tel:(416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com


These press releases may also interest you

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....

at 08:05
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024. About McKesson Corporation...

at 08:05
symplr®, a leading provider of enterprise healthcare operations software, today announced a new partnership integrating award-winning healthcare worker payments technology from Branch, a workforce payments platform. With the integrated pay solution,...



News published on and distributed by: